Published in Stem Cells Int on October 30, 2013
Effects of Exendin-4 on bone marrow mesenchymal stem cell proliferation, migration and apoptosis in vitro. Sci Rep (2015) 0.90
Hypoxia-cultured human adipose-derived mesenchymal stem cells are non-oncogenic and have enhanced viability, motility, and tropism to brain cancer. Cell Death Dis (2014) 0.85
The Potential of GMP-Compliant Platelet Lysate to Induce a Permissive State for Cardiovascular Transdifferentiation in Human Mediastinal Adipose Tissue-Derived Mesenchymal Stem Cells. Biomed Res Int (2015) 0.79
Mesenchymal stem cell therapy for osteoarthritis: current perspectives. Stem Cells Cloning (2015) 0.79
Stem Cell-Based Therapeutics to Improve Wound Healing. Plast Surg Int (2015) 0.78
CD11b+ and Sca-1+ Cells Exert the Main Beneficial Effects of Systemically Administered Bone Marrow-Derived Mononuclear Cells in a Murine Model of Mixed Th2/Th17 Allergic Airway Inflammation. Stem Cells Transl Med (2016) 0.77
The Effect of Culture on Human Bone Marrow Mesenchymal Stem Cells: Focus on DNA Methylation Profiles. Stem Cells Int (2016) 0.76
Substance P enhances the proliferation and migration potential of murine bone marrow-derived mesenchymal stem cell-like cell lines. Exp Ther Med (2015) 0.75
The effects of the DNA methyltranfserases inhibitor 5-Azacitidine on ageing, oxidative stress and DNA methylation of adipose derived stem cells. J Cell Mol Med (2016) 0.75
Methylome Analysis of Human Bone Marrow MSCs Reveals Extensive Age- and Culture-Induced Changes at Distal Regulatory Elements. Stem Cell Reports (2017) 0.75
The hallmarks of cancer. Cell (2000) 113.05
A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A (1995) 32.89
THE LIMITED IN VITRO LIFETIME OF HUMAN DIPLOID CELL STRAINS. Exp Cell Res (1965) 21.61
The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat Genet (2006) 20.76
DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature (2005) 18.30
Stability and flexibility of epigenetic gene regulation in mammalian development. Nature (2007) 14.57
The hallmarks of aging. Cell (2013) 14.29
Switching and signaling at the telomere. Cell (2001) 11.25
A survey of telomerase activity in human cancer. Eur J Cancer (1997) 10.84
Distinct epigenomic landscapes of pluripotent and lineage-committed human cells. Cell Stem Cell (2010) 8.74
The telomere terminal transferase of Tetrahymena is a ribonucleoprotein enzyme with two kinds of primer specificity. Cell (1987) 8.32
The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells. Genes Dev (2007) 6.77
Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer. Genome Res (2010) 6.03
Retracted Spontaneous human adult stem cell transformation. Cancer Res (2005) 4.95
Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone (2003) 4.61
Mesenchymal stem cells derived from dental tissues vs. those from other sources: their biology and role in regenerative medicine. J Dent Res (2009) 4.58
Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation. Cancer Res (2009) 4.58
How telomeres solve the end-protection problem. Science (2009) 4.54
Replicative senescence of mesenchymal stem cells: a continuous and organized process. PLoS One (2008) 4.37
Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Exp Hematol (2005) 4.27
Aging of mesenchymal stem cell in vitro. BMC Cell Biol (2006) 3.32
Telomerase maintains telomere structure in normal human cells. Cell (2003) 3.29
Telomerase expression extends the proliferative life-span and maintains the osteogenic potential of human bone marrow stromal cells. Nat Biotechnol (2002) 3.20
Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms. Cancer Res (2007) 3.19
Study of telomere length reveals rapid aging of human marrow stromal cells following in vitro expansion. Stem Cells (2004) 3.15
Biologic properties of mesenchymal stem cells derived from bone marrow and adipose tissue. J Cell Biochem (2006) 3.11
Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: Implications for their use in cell therapy. Exp Hematol (2000) 2.93
Aberrant epigenetic landscape in cancer: how cellular identity goes awry. Dev Cell (2010) 2.86
DNA methylation pattern changes upon long-term culture and aging of human mesenchymal stromal cells. Aging Cell (2009) 2.84
Hypoxia enhances proliferation and tissue formation of human mesenchymal stem cells. Biochem Biophys Res Commun (2007) 2.67
Aging and replicative senescence have related effects on human stem and progenitor cells. PLoS One (2009) 2.62
Accumulated chromosomal instability in murine bone marrow mesenchymal stem cells leads to malignant transformation. Stem Cells (2005) 2.52
Relationship between donor age and the replicative lifespan of human cells in culture: a reevaluation. Proc Natl Acad Sci U S A (1998) 2.36
Hypoxia inhibits senescence and maintains mesenchymal stem cell properties through down-regulation of E2A-p21 by HIF-TWIST. Blood (2010) 2.22
Clinical-grade production of human mesenchymal stromal cells: occurrence of aneuploidy without transformation. Blood (2009) 2.20
Spontaneous malignant transformation of human mesenchymal stem cells reflects cross-contamination: putting the research field on track - letter. Cancer Res (2010) 2.09
Long-term in vitro expansion alters the biology of adult mesenchymal stem cells. Cancer Res (2008) 2.02
miR-101 is down-regulated in glioblastoma resulting in EZH2-induced proliferation, migration, and angiogenesis. Oncotarget (2010) 1.92
Clinical applications of mesenchymal stem cells. J Hematol Oncol (2012) 1.86
Expansion of mesenchymal stem cells isolated from pediatric and adult donor bone marrow. J Cell Biochem (2006) 1.85
Common fragile sites as targets for chromosome rearrangements. DNA Repair (Amst) (2006) 1.82
Cell specific differences between human adipose-derived and mesenchymal-stromal cells despite similar differentiation potentials. Exp Cell Res (2008) 1.79
Immunomodulatory properties and therapeutic application of mesenchymal stem cells. Clin Exp Immunol (2011) 1.73
Outgrowth of a transformed cell population derived from normal human BM mesenchymal stem cell culture. Cytotherapy (2005) 1.70
Murine but not human mesenchymal stem cells generate osteosarcoma-like lesions in the lung. Stem Cells (2007) 1.59
Replicative senescence of mesenchymal stem cells causes DNA-methylation changes which correlate with repressive histone marks. Aging (Albany NY) (2011) 1.58
Different facets of aging in human mesenchymal stem cells. Tissue Eng Part B Rev (2010) 1.51
A survey of current software for network analysis in molecular biology. Hum Genomics (2010) 1.48
Spontaneous transformation of cultured mouse bone marrow-derived stromal cells. Cancer Res (2006) 1.48
MSCs: Biological characteristics, clinical applications and their outstanding concerns. Ageing Res Rev (2010) 1.43
Lack of telomerase activity in human mesenchymal stem cells. Leukemia (2003) 1.42
Long term culture of mesenchymal stem cells in hypoxia promotes a genetic program maintaining their undifferentiated and multipotent status. BMC Cell Biol (2011) 1.38
Risk factors in the development of stem cell therapy. J Transl Med (2011) 1.38
Chromosome end maintenance by telomerase. J Biol Chem (2009) 1.36
Pitfalls in spontaneous in vitro transformation of human mesenchymal stem cells. Exp Cell Res (2010) 1.35
Telomeres, stem cells, and hematology. Blood (2008) 1.34
How to track cellular aging of mesenchymal stromal cells? Aging (Albany NY) (2010) 1.34
Mesenchymal stromal cell therapy: a revolution in Regenerative Medicine? Bone Marrow Transplant (2011) 1.33
Epigenetic dysregulation in mesenchymal stem cell aging and spontaneous differentiation. PLoS One (2011) 1.30
Telomerase is not an oncogene. Oncogene (2002) 1.29
Telomerase can extend the proliferative capacity of human myoblasts, but does not lead to their immortalization. Mol Cancer Res (2003) 1.28
Optimization of mesenchymal stem cell expansion procedures by cell separation and culture conditions modification. Exp Hematol (2008) 1.27
Cellular senescence: its role in tumor suppression and aging. Cancer Sci (2009) 1.23
Monitoring of cellular senescence by DNA-methylation at specific CpG sites. Aging Cell (2012) 1.22
Retraction: Spontaneous human adult stem cell transformation. Cancer Res (2010) 1.21
Immunomodulatory properties of human adult and fetal multipotent mesenchymal stem cells. J Biomed Sci (2011) 1.20
Dynamics of adipogenic promoter DNA methylation during clonal culture of human adipose stem cells to senescence. BMC Cell Biol (2007) 1.20
Human telomeres are hypersensitive to UV-induced DNA Damage and refractory to repair. PLoS Genet (2010) 1.19
Ex vivo expansion of mesenchymal stromal cells. Best Pract Res Clin Haematol (2011) 1.18
Non-random inactivation of large common fragile site genes in different cancers. Cytogenet Genome Res (2007) 1.15
Mesenchymal stem cells cultured under hypoxia escape from senescence via down-regulation of p16 and extracellular signal regulated kinase. Biochem Biophys Res Commun (2009) 1.13
From cytogenomic to epigenomic profiles: monitoring the biologic behavior of in vitro cultured human bone marrow mesenchymal stem cells. Stem Cell Res Ther (2012) 1.12
Stability of human mesenchymal stem cells during in vitro culture: considerations for cell therapy. Cell Prolif (2012) 1.11
A transformed cell population derived from cultured mesenchymal stem cells has no functional effect after transplantation into the injured heart. Cell Transplant (2009) 1.08
Hypoxia causes downregulation of mismatch repair system and genomic instability in stem cells. Stem Cells (2008) 1.08
Epigenetic maintenance of stemness and malignancy in peripheral neuroectodermal tumors by EZH2. Cell Cycle (2009) 1.06
Cytogenetic analysis of human bone marrow-derived mesenchymal stem cells passaged in vitro. Cell Biol Int (2006) 1.06
Chromosomal variability of human mesenchymal stem cells cultured under hypoxic conditions. J Cell Mol Med (2012) 1.05
Monitoring the genomic stability of in vitro cultured rat bone-marrow-derived mesenchymal stem cells. Chromosome Res (2009) 1.03
Chromatin states of core pluripotency-associated genes in pluripotent, multipotent and differentiated cells. Biochem Biophys Res Commun (2009) 1.00
Optimising human mesenchymal stem cell numbers for clinical application: a literature review. Stem Cells Int (2012) 1.00
DNA methylation in stem cell renewal and multipotency. Stem Cell Res Ther (2011) 1.00
Effects of telomerase modulation in human hematopoietic progenitor cells. Stem Cells (2004) 0.98
Genome-wide analysis of histone H3 lysine9 modifications in human mesenchymal stem cell osteogenic differentiation. PLoS One (2009) 0.96
Epigenetic regulation of mesenchymal stem cells: a focus on osteogenic and adipogenic differentiation. Stem Cells Int (2011) 0.96
Programming differentiation potential in mesenchymal stem cells. Epigenetics (2010) 0.95
Genome-scale DNA methylation pattern profiling of human bone marrow mesenchymal stem cells in long-term culture. Exp Mol Med (2012) 0.92
Ex vivo expansion of human mesenchymal stem cells on microcarriers. Methods Mol Biol (2011) 0.89
Hypoxia and senescence: the impact of oxygenation on tumor suppression. Mol Cancer Res (2011) 0.89
Implications of long-term culture for mesenchymal stem cells: genetic defects or epigenetic regulation? Stem Cell Res Ther (2012) 0.83
Development of bone marrow mesenchymal stem cell culture in vitro. Chin Med J (Engl) (2012) 0.78
Constitutive expression of human telomerase enhances the proliferation potential of human mesenchymal stem cells. Biores Open Access (2012) 0.78
Role of histone deacetylase inhibitors in the aging of human umbilical cord mesenchymal stem cells. J Cell Biochem (2013) 0.78
The impact of culture on epigenetic properties of pluripotent stem cells and pre-implantation embryos. Biochem Soc Trans (2013) 0.77
Paclitaxel and Cisplatin-induced neurotoxicity: a protective role of acetyl-L-carnitine. Clin Cancer Res (2003) 1.45
Maternal polymorphisms for methyltetrahydrofolate reductase and methionine synthetase reductase and risk of children with Down syndrome. Am J Obstet Gynecol (2009) 1.42
A balanced chromosomal translocation disrupting ARHGEF9 is associated with epilepsy, anxiety, aggression, and mental retardation. Hum Mutat (2009) 1.32
Treatment of unruptured cerebral aneurysms by embolization with guglielmi detachable coils: case-fatality, morbidity, and effectiveness in preventing bleeding--a systematic review of the literature. Neurosurgery (2004) 1.32
De novo balanced chromosome rearrangements in prenatal diagnosis. Prenat Diagn (2009) 1.29
Biological heterogeneity of putative bladder cancer stem-like cell populations from human bladder transitional cell carcinoma samples. Cancer Sci (2009) 1.17
Partial duplication of the PARK2 gene in a child with developmental delay and her normal mother: a second report. Am J Med Genet B Neuropsychiatr Genet (2013) 1.16
From cytogenomic to epigenomic profiles: monitoring the biologic behavior of in vitro cultured human bone marrow mesenchymal stem cells. Stem Cell Res Ther (2012) 1.12
Retinoic acid-induced neuritogenesis of human neuroblastoma SH-SY5Y cells is ERK independent and PKC dependent. J Neurosci Res (2004) 1.08
Long-term survival of human neural stem cells in the ischemic rat brain upon transient immunosuppression. PLoS One (2010) 1.05
Monitoring the genomic stability of in vitro cultured rat bone-marrow-derived mesenchymal stem cells. Chromosome Res (2009) 1.03
Autosomal dominant nocturnal frontal lobe epilepsy--a critical overview. J Neurol (2004) 1.01
Multi-transgenic pigs expressing three fluorescent proteins produced with high efficiency by sperm mediated gene transfer. Mol Reprod Dev (2005) 1.00
Chromosomal aberrations in bladder cancer: fresh versus formalin fixed paraffin embedded tissue and targeted FISH versus wide microarray-based CGH analysis. PLoS One (2011) 0.99
A new function of microtubule-associated protein tau: involvement in chromosome stability. Cell Cycle (2008) 0.98
Role of MAPKs in platinum-induced neuronal apoptosis. Neurotoxicology (2009) 0.97
GM3 synthase overexpression results in reduced cell motility and in caveolin-1 upregulation in human ovarian carcinoma cells. Glycobiology (2009) 0.96
ERK1 and ERK2 are involved in recruitment and maturation of human mesenchymal stem cells induced to adipogenic differentiation. J Mol Cell Biol (2011) 0.96
Monitoring techniques for prevention of procedure-related ischemic damage in aneurysm surgery. World Neurosurg (2011) 0.95
Acetyl-L-Carnitine prevents and reverts experimental chronic neurotoxicity induced by oxaliplatin, without altering its antitumor properties. Anticancer Res (2005) 0.95
Lingual vascular canals of the mandible: the risk of bleeding complications during implant procedures. Implant Dent (2007) 0.93
A rescuable folding defective Nav1.1 (SCN1A) sodium channel mutant causes GEFS+: common mechanism in Nav1.1 related epilepsies? Hum Mutat (2009) 0.91
Mapping of candidate region for chordoma development to 1p36.13 by LOH analysis. Int J Cancer (2003) 0.89
Neurotoxicity of platinum compounds: comparison of the effects of cisplatin and oxaliplatin on the human neuroblastoma cell line SH-SY5Y. J Neurooncol (2004) 0.89
Human mesenchymal stem cells express neuronal markers after osteogenic and adipogenic differentiation. Cell Mol Biol Lett (2013) 0.89
Adult mesenchymal stem cells rescue dorsal root ganglia neurons from dying. Brain Res (2006) 0.88
Expression and distribution of 'high affinity' glutamate transporters GLT1, GLAST, EAAC1 and of GCPII in the rat peripheral nervous system. J Anat (2008) 0.88
Mesenchymal stem cells neuronal differentiation ability: a real perspective for nervous system repair? Curr Stem Cell Res Ther (2011) 0.88
Paclitaxel toxicity in post-mitotic dorsal root ganglion (DRG) cells. Anticancer Res (2006) 0.88
NGF protects dorsal root ganglion neurons from oxaliplatin by modulating JNK/Sapk and ERK1/2. Neurosci Lett (2010) 0.88
A glycosphingolipid/caveolin-1 signaling complex inhibits motility of human ovarian carcinoma cells. J Biol Chem (2011) 0.87
Cytogenetics of premature ovarian failure: an investigation on 269 affected women. J Biomed Biotechnol (2011) 0.87
Emerging role of mitogen-activated protein kinases in peripheral neuropathies. J Peripher Nerv Syst (2007) 0.86
Expression of neural markers by undifferentiated rat mesenchymal stem cells. J Biomed Biotechnol (2012) 0.85
Delineating the cytogenomic and epigenomic landscapes of glioma stem cell lines. PLoS One (2013) 0.85
Anatomical organization of the telencephalic connections of the parafascicular nucleus in adult and developing rats. Eur J Neurosci (2003) 0.85
Ophthalmic features in a dysmorphic boy with chromosome 4q deletion and duplication. Ophthalmic Genet (2009) 0.85
Mesenchymal stem cells enhance GABAergic transmission in co-cultured hippocampal neurons. Mol Cell Neurosci (2012) 0.84
Increased spinal cord NGF levels in rats with cobalamin (vitamin B12) deficiency. Neurosci Lett (2005) 0.84
MAP kinase modulation in squamous cell carcinoma of the oral cavity. Anticancer Res (2009) 0.84
Chromosome territories, X;Y translocation and Premature Ovarian Failure: is there a relationship? Mol Cytogenet (2009) 0.84
Association between metalloproteinases 2 and 9 activity and ERK1/2 phosphorylation status in head and neck cancers: an ex vivo study. Oncol Rep (2010) 0.83
Investigating the role of X chromosome breakpoints in premature ovarian failure. Mol Cytogenet (2012) 0.83
Chromosomal imbalances in human bladder urothelial carcinoma: similarities and differences between biopsy samples and cancer stem-like cells. BMC Cancer (2014) 0.83
Exclusion of linkage of nine neuronal nicotinic acetylcholine receptor subunit genes expressed in brain in autosomal dominant nocturnal frontal lobe epilepsy in four unrelated families. J Neurol (2002) 0.82
Frontal lobe epilepsy and mutations of the corticotropin-releasing hormone gene. Ann Neurol (2005) 0.82
Mutations in MAPT gene cause chromosome instability and introduce copy number variations widely in the genome. J Alzheimers Dis (2013) 0.82
Different effects of erythropoietin in cisplatin- and docetaxel-induced neurotoxicity: an in vitro study. J Neurosci Res (2010) 0.82
Systematic chromosomal analysis of cultured mouse neural stem cell lines. Stem Cells Dev (2011) 0.80
Expression of cell cycle regulatory proteins and analysis of apoptosis in normal nasal mucosa and in nasal polyps. Am J Rhinol (2006) 0.80
DNA copy number alterations and PPARG amplification in a patient with multifocal bladder urothelial carcinoma. BMC Res Notes (2012) 0.79
Indirect down-regulation of nuclear NF-kappaB levels by cobalamin in the spinal cord and liver of the rat. J Neurosci Res (2008) 0.79
The fundamental role of morphology in experimental neurotoxicology: the example of chemotherapy-induced peripheral neurotoxicity. Ital J Anat Embryol (2012) 0.79
A de novo supernumerary genomic discontinuous ring chromosome 21 in a child with mild intellectual disability. Am J Med Genet A (2011) 0.79
Interstitial 11q deletion: genomic characterization and neuropsychiatric follow up from early infancy to adolescence and literature review. BMC Res Notes (2014) 0.79
Equal increases in respiratory system elastance reflect similar lung damage in experimental ventilator-induced lung injury. Intensive Care Med (2002) 0.79
Schilder's disease: non-invasive diagnosis? :A case report and review. Neurol Sci (2009) 0.78
Low-dose cisplatin protects human neuroblastoma SH-SY5Y cells from paclitaxel-induced apoptosis. Mol Cancer Ther (2005) 0.78
Neurobasal medium toxicity on mature cortical neurons. Neuroreport (2015) 0.78
Selective reduction of extracellular signal-regulated protein kinase (ERK) phosphorylation in squamous cell carcinoma of the larynx. Oncol Rep (2006) 0.78
Familial subtelomeric rearrangement of chromosomes 19 and 20: a new contribution to partial distal 19q trisomy. Genet Test Mol Biomarkers (2010) 0.78
Maternal heterodisomy/isodisomy and paternal supernumerary ring of chromosome 7 in a child with Silver-Russell syndrome. Clin Dysmorphol (2008) 0.78
Mutations in MAPT give rise to aneuploidy in animal models of tauopathy. Neurogenetics (2013) 0.78
Stem cell augmented mesh materials: an in vitro and in vivo study. Int Urogynecol J (2014) 0.77
The octapeptide repeat PrP(C) region and cobalamin-deficient polyneuropathy of the rat. Muscle Nerve (2011) 0.77
Endometrioid-like yolk sac and Sertoli-Leydig cell tumors in a carrier of a Y heterochromatin insertion into 1qh region: a causal association? Cancer Genet Cytogenet (2007) 0.77
Undifferentiated MSCs are able to myelinate DRG neuron processes through p75. Exp Cell Res (2013) 0.76
Exploiting CD38-mediated endocytosis for immunoliposome internalization. Anticancer Drugs (2008) 0.76
Adult mesenchymal stem cells support cisplatin-treated dorsal root ganglion survival. Neurosci Lett (2008) 0.76
Cobalamin (vitamin B(12)) regulation of PrP(C), PrP(C)-mRNA and copper levels in rat central nervous system. Exp Neurol (2011) 0.75
Increased levels of the CD40:CD40 ligand dyad in the cerebrospinal fluid of rats with vitamin B12(cobalamin)-deficient central neuropathy. J Neuroimmunol (2006) 0.75
Clinical and genetic familial study of a large cohort of Italian children with idiopathic epilepsy. Brain Res Bull (2009) 0.75
A tandem duplication of chromosome 21 in a newborn showing a phenotype inconsistent with Down syndrome. Am J Med Genet A (2010) 0.75
Characterisation of a non-recurrent familial translocation t(7;9)(q11.23;p24.3) points to a recurrent involvement of the Williams-Beuren syndrome region in chromosomal rearrangements. J Hum Genet (2005) 0.75
A new human cell line, PDSS-26, from poorly differentiated synovial sarcoma, with unique chromosomal anomalies. Cancer Genet Cytogenet (2003) 0.75
Role of FISH on uncultured amniocytes for the diagnosis of aneuploidies in the presence of fetal anomalies. Fetal Diagn Ther (2004) 0.75
Evidence for a fourth locus for autosomal dominant nocturnal frontal lobe epilepsy. Brain Res Bull (2004) 0.75
Severe intrauterine growth restriction and trisomy 15 confined placental mosaicism: a case report and review of literature. Prenat Diagn (2005) 0.75
Mutational analysis of nicotinic acetylcholine receptor beta2 subunit gene (CHRNB2) in a representative cohort of Italian probands affected by autosomal dominant nocturnal frontal lobe epilepsy. Epilepsia (2002) 0.75
Fetal trisomy 5 mosaicism: case report and literature review. Am J Med Genet A (2007) 0.75